Advanced search
Publication Cover
Expert Review of Vaccines Volume 6, 2007 - Issue 2
Submit an article Journal homepage
50
Views
13
CrossRef citations to date
0
Altmetric
Review

Potential of active and passive immunizations for the prevention and therapy of transmissible spongiform encephalopathies

Steffen Bade Postdoctoral Research Fellow, Research Center Borstel, Division of Mucosal Immunology, Parkallee 22, D-23845 Borstel, Germany. [email protected]
&
Andreas Frey Divisional Head, Research Center Borstel, Division of Mucosal Immunology, Parkallee 22, D-23845 Borstel, Germany. [email protected]
Pages 153-168 | Published online: 09 Jan 2014

References

  • Prusiner SB. Novel proteinaceous infectious particles cause scrapie. Science216(4542), 136–144 (1982).
  • Papassotiropoulos A, Wollmer MA, Aguzzi A et al. The prion gene is associated with human long-term memory. Hum. Mol. Genet.14(15), 2241–2246 (2005).
  • Martins VR, Linden R, Prado MA et al. Cellular prion protein: on the road for functions. FEBS Lett.512(1–3), 25–28 (2002).
  • Bueler H, Aguzzi A, Sailer A et al. Mice devoid of PrP are resistant to scrapie. Cell73(7), 1339–1347 (1993).
  • Prusiner SB, Groth D, Serban A et al. Ablation of the prion protein (PrP) gene in mice prevents scrapie and facilitates production of anti-PrP antibodies. Proc. Natl Acad. Sci. USA90(22), 10608–10612 (1993).
  • Glatzel M, Heppner FL, Albers KM, Aguzzi A. Sympathetic innervation of lymphoreticular organs is rate limiting for prion neuroinvasion. Neuron31(1), 25–34 (2001).
  • Mabbott NA, Macpherson GG. Prions and their lethal journey to the brain. Nat. Rev. Microbiol.4(3), 201–211 (2006).
  • Pan KM, Baldwin M, Nguyen J et al. Conversion of α-helices into β-sheets features in the formation of the scrapie prion proteins. Proc. Natl Acad. Sci. USA90(23), 10962–10966 (1993).
  • McKinley MP, Bolton DC, Prusiner SB. A protease-resistant protein is a structural component of the scrapie prion. Cell35(1), 57–62 (1983).
  • Taylor DM, Fraser H, McConnell I et al. Decontamination studies with the agents of bovine spongiform encephalopathy and scrapie. Arch. Virol.139(3–4), 313–326 (1994).
  • Brown P, Gajdusek DC. Survival of scrapie virus after 3 years’ interment. Lancet337(8736), 269–270 (1991).
  • Brown P, Brandel JP, Preece M, Sato T. Iatrogenic Creutzfeldt–Jakob disease: the waning of an era. Neurology67(3), 389–393 (2006).
  • Will RG, Ironside JW, Zeidler M et al. A new variant of Creutzfeldt–Jakob disease in the UK. Lancet347(9006), 921–925 (1996).
  • Zeidler M, Stewart GE, Barraclough CR et al. New variant Creutzfeldt–Jakob disease: neurological features and diagnostic tests. Lancet350(9082), 903–907 (1997).
  • Lasmezas CI, Deslys JP, Demaimay R et al. BSE transmission to macaques. Nature381(6585), 743–744 (1996).
  • Bruce ME, Will RG, Ironside JW et al. Transmissions to mice indicate that ‘new variant’ CJD is caused by the BSE agent. Nature389(6650), 498–501 (1997).
  • Myles S, Douglas MJ, Ward HJ, Campbell H, Will RG. Variant Creutzfeldt–Jakob disease: costs borne by families. Health Soc. Care Community10(2), 91–98 (2002).
  • Collinge J, Whitfield J, McKintosh E et al. Kuru in the 21st century – an acquired human prion disease with very long incubation periods. Lancet367(9528), 2068–2074 (2006).
  • Brown P, Abee CR. Working with transmissible spongiform encephalopathy agents. ILAR J.46(1), 44–52 (2005).
  • Thomzig A, Cardone F, Kruger D et al. Pathological prion protein in muscles of hamsters and mice infected with rodent-adapted BSE or vCJD. J. Gen. Virol.87(Pt 1), 251–254 (2006).
  • Angers RC, Browning SR, Seward TS et al. Prions in skeletal muscles of deer with chronic wasting disease. Science311(5764), 1117 (2006).
  • Heikenwalder M, Zeller N, Seeger H et al. Chronic lymphocytic inflammation specifies the organ tropism of prions. Science307(5712), 1107–1110 (2005).
  • Mathiason CK, Powers JG, Dahmes SJ et al. Infectious prions in the saliva and blood of deer with chronic wasting disease. Science314(5796), 133–136 (2006).
  • Miller MW, Williams ES, Hobbs NT, Wolfe LL. Environmental sources of prion transmission in mule deer. Emerg. Infect. Dis.10(6), 1003–1006 (2004).
  • Bartz JC, Marsh RF, McKenzie DI, Aiken JM. The host range of chronic wasting disease is altered on passage in ferrets. Virology251(2), 297–301 (1998).
  • Belay ED, Maddox RA, Williams ES et al. Chronic wasting disease and potential transmission to humans. Emerg. Infect. Dis.10(6), 977–984 (2004).
  • Diringer H, Roehmel J, Beekes M. Effect of repeated oral infection of hamsters with scrapie. J. Gen. Virol.79(Pt 3), 609–612 (1998).
  • Jacquemot C, Cuche C, Dormont D, Lazarini F. High incidence of scrapie induced by repeated injections of subinfectious prion doses. J. Virol.79(14), 8904–8908 (2005).
  • Heppner FL, Christ AD, Klein MA et al. Transepithelial prion transport by M cells. Nat. Med.7(9), 976–977 (2001).
  • Bergstrom AL, Jensen TK, Heegaard PM et al. Short-term study of the uptake of PrP(Sc) by the Peyer’s patches in hamsters after oral exposure to scrapie. J. Comp. Pathol.134(2–3), 126–133 (2006).
  • Neutra MR, Frey A, Kraehenbuhl JP. Epithelial M cells: gateways for mucosal infection and immunization. Cell86(3), 345–348 (1996).
  • Beekes M, McBride PA. Early accumulation of pathological PrP in the enteric nervous system and gut-associated lymphoid tissue of hamsters orally infected with scrapie. Neurosci. Lett.278(3), 181–184 (2000).
  • Huang FP, Farquhar CF, Mabbott NA, Bruce ME, MacPherson GG. Migrating intestinal dendritic cells transport PrP(Sc) from the gut. J. Gen. Virol.83(Pt 1), 267–271 (2002).
  • Rescigno M, Urbano M, Valzasina B et al. Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria. Nat. Immunol.2(4), 361–367 (2001).
  • Scherbel C, Pichner R, Groschup MH et al. Degradation of scrapie associated prion protein (PrP(Sc)) by the gastrointestinal microbiota of cattle. Vet. Res.37(5), 695–703 (2006).
  • Mishra RS, Basu S, Gu Y et al. Protease-resistant human prion protein and ferritin are cotransported across Caco-2 epithelial cells: implications for species barrier in prion uptake from the intestine. J. Neurosci.24(50), 11280–11290 (2004).
  • Prinz M, Heikenwalder M, Junt T et al. Positioning of follicular dendritic cells within the spleen controls prion neuroinvasion. Nature425(6961), 957–962 (2003).
  • Neutra MR, Kozlowski PA. Mucosal vaccines: the promise and the challenge. Nat. Rev. Immunol.6(2), 148–158 (2006).
  • Phalipon A, Cardona A, Kraehenbuhl JP et al. Secretory component: a new role in secretory IgA-mediated immune exclusion in vivo. Immunity17(1), 107–115 (2002).
  • Holmgren J, Czerkinsky C. Mucosal immunity and vaccines. Nat. Med.11(Suppl. 4), S45–S53 (2005).
  • Heppner FL, Musahl C, Arrighi I et al. Prevention of scrapie pathogenesis by transgenic expression of anti-prion protein antibodies. Science294(5540), 178–182 (2001).
  • Mallucci G, Dickinson A, Linehan J et al. Depleting neuronal PrP in prion infection prevents disease and reverses spongiosis. Science302(5646), 871–874 (2003).
  • Souan L, Tal Y, Felling Y et al. Modulation of proteinase-K resistant prion protein by prion peptide immunization. Eur. J. Immunol.31(8), 2338–2346 (2001).
  • Koller MF, Grau T, Christen P. Induction of antibodies against murine full-length prion protein in wild-type mice. J. Neuroimmunol.132(1–2), 113–116 (2002).
  • Sigurdsson EM, Brown DR, Daniels M et al. Immunization delays the onset of prion disease in mice. Am. J. Pathol.161(1), 13–17 (2002).
  • Polymenidou M, Heppner FL, Pellicioli EC et al. Humoral immune response to native eukaryotic prion protein correlates with anti-prion protection. Proc. Natl Acad. Sci. USA101(Suppl. 2), 14670–14676 (2004).
  • Gilch S, Wopfner F, Renner-Muller I et al. Polyclonal anti-PrP auto-antibodies induced with dimeric PrP interfere efficiently with PrPSc propagation in prion-infected cells. J. Biol. Chem.278(20), 18524–18531 (2003).
  • Nikles D, Bach P, Boller K et al. Circumventing tolerance to the prion protein (PrP): vaccination with PrP-displaying retrovirus particles induces humoral immune responses against the native form of cellular PrP. J. Virol.79(7), 4033–4042 (2005).
  • Andrievskaia O, McRae H, Elmgren C et al. Generation of antibodies against bovine recombinant prion protein in various strains of mice. Clin. Vaccine Immunol.13(1), 98–105 (2006).
  • Ishibashi D, Yamanaka H, Yamaguchi N et al. Immunization with recombinant bovine but not mouse prion protein delays the onset of disease in mice inoculated with a mouse-adapted prion. Vaccine25(6), 985–992 (2006).
  • Rosset MB, Ballerini C, Gregoire S et al. Breaking immune tolerance to the prion protein using prion protein peptides plus oligodeoxynucleotide-CpG in mice. J. Immunol.172(9), 5168–5174 (2004).
  • Gregoire S, Bergot AS, Feraudet C et al. The murine B cell repertoire is severely selected against endogenous cellular prion protein. J. Immunol.175(10), 6443–6449 (2005).
  • Tal Y, Souan L, Cohen IR et al. Complete Freund’s adjuvant immunization prolongs survival in experimental prion disease in mice. J. Neurosci. Res.71(2), 286–290 (2003).
  • Oboznaya MB, Gilch S, Titova MA et al. Antibodies to a nonconjugated prion protein peptide 95–123 interfere with PrP(Sc) propagation in prion-infected cells. Cell. Mol. Neurobiol. DOI: 10.1007/s10571-006-9108-y (2007) (Epub ahead of print).
  • Arbel M, Lavie V, Solomon B. Generation of antibodies against prion protein in wild-type mice via helix 1 peptide immunization. J. Neuroimmunol.144(1–2), 38–45 (2003).
  • Bainbridge J, Jones N, Walker B. Multiple antigenic peptides facilitate generation of anti-prion antibodies. Clin. Exp. Immunol.137(2), 298–304 (2004).
  • Schwarz A, Kratke O, Burwinkel M et al.. Immunisation with a synthetic prion protein-derived peptide prolongs survival times of mice orally exposed to the scrapie agent. Neurosci. Lett.350(3), 187–189 (2003).
  • Magri G, Clerici M, Dall’ara P et al. Decrease in pathology and progression of scrapie after immunisation with synthetic prion protein peptides in hamsters. Vaccine23(22), 2862–2868 (2005).
  • Muller S, Kehm R, Handermann M et al. Testing the possibility to protect bovine PrPC transgenic Swiss mice against bovine PrPSc infection by DNA vaccination using recombinant plasmid vectors harboring and expressing the complete or partial cDNA sequences of bovine PrPC. Virus Genes30(2), 279–296 (2005).
  • Fernandez-Borges N, Brun A, Whitton JL et al. DNA vaccination can break immunological tolerance to PrP in wild-type mice and attenuates prion disease after intracerebral challenge. J. Virol.80(20), 9970–9976 (2006).
  • Goni F, Knudsen E, Schreiber F et al. Mucosal vaccination delays or prevents prion infection via an oral route. Neuroscience133(2), 413–421 (2005).
  • Bade S, Baier M, Boetel T, Frey A. Intranasal immunization of Balb/c mice against prion protein attenuates orally acquired transmissible spongiform encephalopathy. Vaccine24(9), 1242–1253 (2006).
  • Baier M, Norley S, Schultz J et al. Prion diseases: infectious and lethal doses following oral challenge. J. Gen. Virol.84(Pt 7), 1927–1929 (2003).
  • Yamanaka H, Ishibashi D, Yamaguchi N et al. Enhanced mucosal immunogenicity of prion protein following fusion with B subunit of Escherichia coli heat-labile enterotoxin. Vaccine24(15), 2815–2823 (2006).
  • Sigurdsson EM, Sy MS, Li R et al. Anti-prion antibodies for prophylaxis following prion exposure in mice. Neurosci. Lett.336(3), 185–187 (2003).
  • Pankiewicz J, Prelli F, Sy MS et al. Clearance and prevention of prion infection in cell culture by anti-PrP antibodies. Eur. J. Neurosci.23(10), 2635–2647 (2006).
  • White AR, Enever P, Tayebi M et al. Monoclonal antibodies inhibit prion replication and delay the development of prion disease. Nature422(6927), 80–83 (2003).
  • Kascsak RJ, Rubenstein R, Merz PA et al. Mouse polyclonal and monoclonal antibody to scrapie-associated fibril proteins. J. Virol.61(12), 3688–3693 (1987).
  • Khalili-Shirazi A, Quaratino S, Londei M et al. Protein conformation significantly influences immune responses to prion protein. J. Immunol.174(6), 3256–3263 (2005).
  • Miyamoto K, Nakamura N, Aosasa M et al. Inhibition of prion propagation in scrapie-infected mouse neuroblastoma cell lines using mouse monoclonal antibodies against prion protein. Biochem. Biophys. Res. Commun.335(1), 197–204 (2005).
  • Korth C, Stierli B, Streit P et al. Prion (PrPSc)-specific epitope defined by a monoclonal antibody. Nature390(6655), 74–77 (1997).
  • Enari M, Flechsig E, Weissmann C. Scrapie prion protein accumulation by scrapie-infected neuroblastoma cells abrogated by exposure to a prion protein antibody. Proc. Natl Acad. Sci. USA98(16), 9295–9299 (2001).
  • Perrier V, Solassol J, Crozet C et al. Anti-PrP antibodies block PrPSc replication in prion-infected cell cultures by accelerating PrPC degradation. J. Neurochem.89(2), 454–463 (2004).
  • Kim CL, Umetani A, Matsui T et al. Antigenic characterization of an abnormal isoform of prion protein using a new diverse panel of monoclonal antibodies. Virology320(1), 40–51 (2004).
  • Kim CL, Karino A, Ishiguro N et al. Cell-surface retention of PrPC by anti-PrP antibody prevents protease-resistant PrP formation. J. Gen. Virol.85(Pt 11), 3473–3482 (2004).
  • Feraudet C, Morel N, Simon S et al. Screening of 145 anti-PrP monoclonal antibodies for their capacity to inhibit PrPSc replication in infected cells. J. Biol. Chem.280(12), 11247–11258 (2005).
  • Beringue V, Vilette D, Mallinson G et al. PrPSc binding antibodies are potent inhibitors of prion replication in cell lines. J. Biol. Chem.279(38), 39671–39676 (2004).
  • Knight DM, Wagner C, Jordan R et al. The immunogenicity of the 7E3 murine monoclonal Fab antibody fragment variable region is dramatically reduced in humans by substitution of human for murine constant regions. Mol. Immunol.32(16), 1271–1281 (1995).
  • Peretz D, Williamson RA, Kaneko K et al. Antibodies inhibit prion propagation and clear cell cultures of prion infectivity. Nature412(6848), 739–743 (2001).
  • Solforosi L, Criado JR, McGavern DB et al. Cross-linking cellular prion protein triggers neuronal apoptosis in vivo. Science303(5663), 1514–1516 (2004).
  • Donofrio G, Heppner FL, Polymenidou M, Musahl C, Aguzzi A. Paracrine inhibition of prion propagation by anti-PrP single-chain Fv miniantibodies. J. Virol.79(13), 8330–8338 (2005).
  • Cardinale A, Filesi I, Vetrugno V et al. Trapping prion protein in the endoplasmic reticulum impairs PrPC maturation and prevents PrPSc accumulation. J. Biol. Chem.280(1), 685–694 (2005).
  • Vetrugno V, Cardinale A, Filesi I et al. KDEL-tagged anti-prion intrabodies impair PrP lysosomal degradation and inhibit scrapie infectivity. Biochem. Biophys. Res. Commun.338(4), 1791–1797 (2005).
  • Busse W, Corren J, Lanier BQ et al. Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthma. J. Allergy Clin. Immunol.108(2), 184–190 (2001).
  • Paramithiotis E, Pinard M, Lawton T et al. A prion protein epitope selective for the pathologically misfolded conformation. Nat. Med.9(7), 893–899 (2003).
  • Williamson RA, Peretz D, Pinilla C et al. Mapping the prion protein using recombinant antibodies. J. Virol.72(11), 9413–9418 (1998).
  • Novitskaya V, Makarava N, Bellon A et al. Probing the conformation of the prion protein within a single amyloid fibril using a novel immunoconformational assay. J. Biol. Chem.281(22), 15536–15545 (2006).
  • Zanusso G, Liu D, Ferrari S et al. Prion protein expression in different species: analysis with a panel of new mAbs. Proc. Natl Acad. Sci. USA95(15), 8812–8816 (1998).
  • Li R, Liu T, Wong BS et al. Identification of an epitope in the C terminus of normal prion protein whose expression is modulated by binding events in the N terminus. J. Mol. Biol.301(3), 567–573 (2000).
  • Pan T, Li R, Kang SC et al. Epitope scanning reveals gain and loss of strain specific antibody binding epitopes associated with the conversion of normal cellular prion to scrapie prion. J. Neurochem.90(5), 1205–1217 (2004).
  • Pan T, Wong P, Chang B et al. Biochemical fingerprints of prion infection: accumulations of aberrant full-length and N-terminally truncated PrP species are common features in mouse prion disease. J. Virol.79(2), 934–943 (2005).
  • Beringue V, Mallinson G, Kaisar M et al. Regional heterogeneity of cellular prion protein isoforms in the mouse brain. Brain126(Pt 9), 2065–2073 (2003).

Websites

  • World organization for animal health (OIE). Number of cases of BSE reported in the UK www.oie.int/eng/info/en_esbru.htm
  • World organization for animal health (OIE). Number of reported cases of BSE worldwide www.oie.int/eng/info/en_esbmonde.htm
  • EUROPA. Food safety. Biological safety of Food – BSE ec.europa.eu/food/food/biosafety/bse/ index_en.htm
  • Canadian Food Inspection Agency. Risk assessment on BSE in cattle in Canada. Part C: risk estimation www.inspection.gc.ca/english/sci/ahra/ bseris/bserisc2e.shtml
  • Creutzfeldt Jakob disease Certificates www.cjd.ed.ac.uk/figures.htm
  • Diagnosis, treatment and care of vCJD patients (Vol. 8) www.bseinquiry.gov.uk/report/volume8/ chaptec5.htm
  • World organization for animal health (OIE) www.oie.int

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.